FLCCC Alliance

High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (COLDSTER).

Published On: February 17, 2022|
Print Friendly, PDF & Email